Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Experimental and Molecular Pathology|December 26, 2013
miR-126 in human cancers: clinical roles and current perspectivesFaeza Ebrahimi, Vinod Gopalan, Robert Anthony Smith, et al.
Experimental and Molecular Pathology|August 8, 2014
Role of microRNA-34 family in cancer with particular reference to cancer angiogenesisHamidreza Maroof, Ali Salajegheh, Robert Anthony Smith, et al.
Biology of the Cell|December 30, 2015
Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cellsAfraa Mamoori, Vinod Gopalan, Robert Anthony Smith, et al.
Endocrine-Related Cancer|January 11, 2018
miR-205 targets angiogenesis and EMT concurrently in anaplastic thyroid carcinomaHaleh Vosgha, Armin Ariana, Robert Anthony Smith, et al.
BMC Genomics|August 17, 2017
Leveraging network analytics to infer patient syndrome and identify causal genes in rare disease casesAndreas Krämer, Sohela Shah, Robert Anthony Rebres, et al.
Experimental and Molecular Pathology|September 26, 2015
Multiple proliferation-survival signalling pathways are simultaneously active in BRAF V600E mutated thyroid carcinomasMd Atiqur Rahman, Ali Salajegheh, Robert Anthony Smith, et al.
International Journal of Colorectal Disease|August 6, 2010
Signet-ring cell carcinoma of colorectum--current perspectives and molecular biologyVinod Gopalan, Robert Anthony Smith, Yik-Hong Ho, et al.
Human Pathology|June 13, 2008
Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activityAlfred King-Yin Lam, Said Saleh, Robert Anthony Smith, et al.
Experimental Cell Research|September 20, 2015
MicroRNA-126 suppresses proliferation of undifferentiated (BRAF(V600E) and BRAF(WT)) thyroid carcinoma through targeting PIK3R2 gene and repressing PI3K-AKT proliferation-survival signalling pathwayMd Atiqur Rahman, Ali Salajegheh, Robert Anthony Smith, et al.
Endocrine|May 16, 2016
Inhibition of BRAF kinase suppresses cellular proliferation, but not enough for complete growth arrest in BRAF V600E mutated papillary and undifferentiated thyroid carcinomasMd Atiqur Rahman, Ali Salajegheh, Robert Anthony Smith, et al.
Pageof 8